Clinical trials and rare diseases

New England Journal of Medicine

Volumn 348, Issue 24, 2003, Pages 2455-2456

  Lagakos, Stephen W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE; PLACEBO;

ANTIFUNGAL ACTIVITY; CLINICAL TRIAL; EDITORIAL; GRANULOMATOUS INFLAMMATION; HEALTH HAZARD; HUMAN; MYCOSIS; PRIORITY JOURNAL;

ADULT; ANTIFUNGAL AGENTS; CHILD; DATA INTERPRETATION, STATISTICAL; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; ITRACONAZOLE; MYCOSES; RANDOMIZED CONTROLLED TRIALS; RARE DISEASES; RESEARCH DESIGN;

EID: 0037905488     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMe030024     Document Type: Editorial

References (6)

1. Gallin JI, Alling DW, Malech HL, et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J j Med 2003;348:2416-22.
2. Bailar JC III, Mosteller F, eds. Medical uses of statistics. 2nd ed. Waltham, Mass.: NEJM Books, 1992.
3. Kwong KK, Belliveau JW, Chesler DA, et al. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci U S A 1992;89:5675-9.
4. Zelen M. Play the winner rule and the controlled clinical trial. J Am Stat Assoc 1969;64:131-46.
5. Wei LJ, Durham S. The randomized play-the-winner rule in medical trials. J Am Stat Assoc 1978;73:840-3.
6. Ware JH. Investigating therapies of potentially great benefit: ECMO. Stat Sci 1989;4:298-340.